Ecotypes of triple-negative breast cancer in response to chemotherapy

Researchers found that macrophage subtypes and cancer-cell metaprograms are associated with a good response to neoadjuvant chemotherapy in triple-negative breast cancer patients. The study highlights the importance of interferon signalling, HLA expression, and cell cycle activity in treatment outcomes. This discovery could lead to more effective personalized treatment strategies.